US2004077038A1PendingUtilityA1

Methods for production of proteins in host cells

Priority: Dec 23, 1999Filed: Nov 13, 2003Published: Apr 22, 2004
Est. expiryDec 23, 2019(expired)· nominal 20-yr term from priority
C12N 15/70
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides methods for the production of proteins, particularly toxic proteins, in host cells. The invention provides methods which use a fusion protein comprising a chaperonin binding domain in host cells induced or regulated to have increased levels of chaperonin which binds the chaperonin binding domain.

Claims

exact text as granted — not AI-modified
We claim:  
     
         1 . A method for producing a protein in a host cell, comprising the step of culturing a host cell comprising a first nucleic acid encoding an isolated chaperonin binding domain associated with a second nucleic acid encoding the protein and a third nucleic acid encoding a chaperonin, under conditions suitable for expression of said first, said second and said third nucleic acid and wherein said chaperonin binding domain is capable of binding to said chaperonin.  
     
     
         2 . The method of  claim 1  further comprising recovering said protein from said cell.  
     
     
         3 . The method of  claim 1  wherein said nucleic acid encoding the chaperonin is naturally produced by the host cell.  
     
     
         4 . The method of  claim 3  wherein said cell is grown under conditions that result in elevation of the levels of the naturally produced chaperonin.  
     
     
         5 . The method of  claim 1  wherein said nucleic acid encoding the chaperonin is heterologous to the host cell.  
     
     
         6 . The method of  claim 1  wherein said host cell is a bacterial cell.  
     
     
         7 . The method of  claim 6  wherein said bacterial cell is a member of the family Enterobacteriaceae  
     
     
         8 . The method of  claim 7  wherein said bacterial cell is  E. coli.    
     
     
         9 . The method of  claim 1  wherein the chaperonin binding domain has a sequence as shown in SEQ ID NO: 1 through SEQ ID NO: 38.  
     
     
         10 . The method of  claim 1  wherein said chaperonin binding domain is obtainable from GroES and said chaperonin is the GroEL chaperonin.  
     
     
         11 . The method of  claim 10  wherein the chaperonin binding domain comprises the amino acid sequence EVETKSAGGIVLTGSAAA or is a variation thereof capable of binding to GroEL chaperonin with an affinity of between about 10 −2  and 10 −8  Kd.  
     
     
         12 . The method of  claim 1  wherein said first and said second nucleic acid encode a fusion protein.  
     
     
         13 . The method of  claim 12  wherein said first and said second nucleic acid encode a fusion protein and are separated by an enzymatic cleavage site.  
     
     
         14 . The method of  claim 12  wherein said first and said second nucleic acid encode a fusion protein and are separated by a chemical cleavage site.  
     
     
         15 . The method of  claim 1  wherein said protein is toxic to the host cell.  
     
     
         16 . The method of  claim 5  wherein said chaperonin heterologous to the host cell is under the control of an expression signal capable of overexpression said chaperonin.  
     
     
         17 . An expression vector comprising a first nucleic acid encoding a chaperonin binding domain and a second nucleic acid encoding a protein.  
     
     
         18 . The expression vector of  claim 17  wherein the chaperonin binding domain has a sequence as shown in SEQ ID NO: 1 through SEQ ID NO: 38  
     
     
         19 . The expression vector of  claim 18  wherein the chaperonin binding domain is obtainable from GroES.  
     
     
         20 . The expression vector of  claim 18  wherein the chaperonin binding domain comprises the amino acid sequence EVETKSAGGIVLTGSAAA or a variation thereof capable of binding to GroEL chaperonin with an affinity of between about 10 −2  and 10 −8  Kd.  
     
     
         21 . A host cell containing the expression vector of  claim 17 .  
     
     
         22 . The host cell of  claim 21  wherein the host cell is a member of the family Enterobacteriaceae.  
     
     
         23 . The host cell of  claim 22  wherein the host cell is  E. coli.

Join the waitlist — get patent alerts

Track US2004077038A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.